Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company‚Äôs equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportFiling
2022-07-28
5:06 pm
Purchase
13DOncoCyte Corporation
OCX
BROADWOOD PARTNERS L.P.30,212,899
24.1%
6,437,935increase
(+27.08%)
View
2022-04-15
5:21 pm
Purchase
13DOncoCyte Corporation
OCX
BROADWOOD PARTNERS L.P.23,774,964
19.99%
5,939,374increase
(+33.30%)
View
2022-03-25
5:23 pm
Purchase
13DLineage Cell Therapeutics, Inc.
LCTX
BROADWOOD PARTNERS L.P.35,227,273
20.7%
980,106increase
(+2.86%)
View
2021-10-01
4:59 pm
Sale
13DSTAAR Surgical Company
STAA
BROADWOOD PARTNERS L.P.8,617,907
18.2%
-408,350decrease
(-4.52%)
View
2021-09-24
4:40 pm
Unchanged
13DOncoCyte Corporation
OCX
BROADWOOD PARTNERS L.P.17,835,590
19.3%
0
(Unchanged)
View
2021-06-15
8:46 pm
Sale
13DSTAAR Surgical Company
STAA
BROADWOOD PARTNERS L.P.9,026,257
19.2%
-443,734decrease
(-4.69%)
View
2021-04-05
5:12 pm
Sale
13DSTAAR Surgical Company
STAA
BROADWOOD PARTNERS L.P.9,469,991
20.3%
-455,931decrease
(-4.59%)
View
2021-03-16
5:04 pm
Purchase
13DLineage Cell Therapeutics, Inc.
LCTX
BROADWOOD PARTNERS L.P.34,247,167
21.2%
335,268increase
(+0.99%)
View
2021-02-09
5:10 pm
Purchase
13DOncoCyte Corporation
OCX
BROADWOOD PARTNERS L.P.17,835,590
20.1%
600,000increase
(+3.48%)
View
2021-01-28
5:25 pm
Sale
13DSTAAR Surgical Company
STAA
BROADWOOD PARTNERS L.P.9,925,922
21.5%
-895,326decrease
(-8.27%)
View
2021-01-22
4:18 pm
Purchase
13DOncoCyte Corporation
OCX
BROADWOOD PARTNERS L.P.17,235,590
21.6%
5,078,217increase
(+41.77%)
View
2020-08-12
5:05 pm
Sale
13DSTAAR Surgical Company
STAA
BROADWOOD PARTNERS L.P.10,821,248
23.6%
-59,831decrease
(-0.55%)
View
2019-09-13
5:08 pm
Purchase
13DOncoCyte Corporation
OCX
BROADWOOD PARTNERS L.P.12,157,373
22.9%
2,000,000increase
(+19.69%)
View
2019-07-02
5:09 pm
Purchase
13DOncoCyte Corporation
OCX
BROADWOOD PARTNERS L.P.10,157,373
19.2%
1,000,000increase
(+10.92%)
View
2019-03-12
5:02 pm
Purchase
13DLineage Cell Therapeutics Inc.
BTX
BROADWOOD PARTNERS L.P.33,911,899
22.4%
6,579,737increase
(+24.07%)
View
2019-03-12
4:50 pm
Sale
13DAsterias Biotherapeutics Inc.
AST
BROADWOOD PARTNERS L.P.0
0%
-4,028,053decrease
(Position Closed)
View
2019-02-12
5:16 pm
Purchase
13DOncoCyte Corporation
OCX
BROADWOOD PARTNERS L.P.9,157,373
17.5%
533,333increase
(+6.18%)
View
2018-12-10
4:15 pm
Purchase
13GAgeX Therapeutics, Inc.
AGE
BROADWOOD PARTNERS L.P.3,003,446
8.4%
3,003,446increase
(New Position)
View
2018-08-10
5:25 pm
Purchase
13DSTAAR Surgical Company
STAA
BROADWOOD PARTNERS L.P.10,881,079
24.8%
14,144increase
(+0.13%)
View
2018-03-30
4:35 pm
Purchase
13DOncoCyte Corporation
OCX
BROADWOOD PARTNERS L.P.8,624,040
21.3%
4,453,897increase
(+106.80%)
View